Santen Pharmaceutical Controller Salaries in Boulder | Comparably
Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products read more
EMPLOYEE
PARTICIPANTS
11
TOTAL
RATINGS
131

Santen Pharmaceutical Controller Salaries in Boulder

The average Santen Pharmaceutical Controller in Boulder earns an estimated $130,332 annually. Santen Pharmaceutical's Controller compensation is $7,053 more than the US average for a Controller.

In Boulder, The Finance Department at Santen Pharmaceutical earns $4,091 more on average than the Business Development Department.

Last updated 4 years ago.

$47k
$71k
$95k
$118k
$180k
$240k
$300k
$130,332
Average Compensation
$130,332
avg. base

Controller Salaries at Santen Pharmaceutical

In Boulder, Controllers earn $19,005 more than Accounting Managers.

Accounting Manager
$111k*
Financial Analyst
$92k*
Business Analyst
$88k*
Senior Accountant
$78k*
Accountant
$54k*
* estimated salary

Compensation at Santen Pharmaceutical by Department

In Boulder, The Finance Department averages $4,091 more than the Business Development Department, and $6,853 less than the Sales Department

Sales
$102,160 Avg. total comp.
+$7k
Finance
$95,307 Avg. total comp.
Business Development
$91,216 Avg. total comp.
-$4k

Controller Compensation by Gender (All Companies)

The average female Controller at companies similar size to Santen Pharmaceutical reported making $170,350, while the average male Controller at similar sized companies reported making $144,104.

Controller Compensation by Ethnicity (All Companies)

The average Caucasian Controller at companies similar size to Santen Pharmaceutical reported making $152,054, while the average Asian or Pacific Islander Controller at similar sized companies reported making $137,500.

How Controllers at Santen Pharmaceutical Rate Their Compensation

The majority of Controllers at Santen Pharmaceutical believe they're not compensated fairly. 50% of Controllers at Santen Pharmaceutical say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Santen Pharmaceutical

×
Rate your company